Your browser doesn't support javascript.
loading
One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy.
Ito, Arisa; Maruyama-Inoue, Maiko; Kitajima, Yoko; Ikeda, Shoko; Inoue, Tatsuya; Kadonosono, Kazuaki.
Affiliation
  • Ito A; Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
  • Maruyama-Inoue M; Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan. maicoo@urahp.yokohama-cu.ac.jp.
  • Kitajima Y; Department of Ophthalmology, Sakae Kyosai Hospital, Kanagawa, Japan.
  • Ikeda S; Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
  • Inoue T; Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
  • Kadonosono K; Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
Sci Rep ; 12(1): 7987, 2022 05 14.
Article in En | MEDLINE | ID: mdl-35568780

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Vascular Endothelial Growth Factor / Eye Diseases Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Vascular Endothelial Growth Factor / Eye Diseases Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom